These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 32738228

  • 1. Vogt-Koyanagi-Harada Disease Managed With Immunomodulatory Therapy Within 3 Months of Disease Onset.
    Ei Ei Lin Oo, Chee SP, Wong KKY, Hla Myint Htoon.
    Am J Ophthalmol; 2020 Dec; 220():37-44. PubMed ID: 32738228
    [Abstract] [Full Text] [Related]

  • 2. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
    Chee SP, Jap A.
    Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A.
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [Abstract] [Full Text] [Related]

  • 4. EFFICACY OF COMBINED SYSTEMIC CORTICOSTEROID AND EARLY IMMUNOMODULATORY THERAPY WITHIN THREE MONTHS OF ONSET IN VOGT-KOYANAGI-HARADA DISEASE.
    Park HS, Park HY, Lee CS, Lee SC, Lee JH.
    Retina; 2022 Dec 01; 42(12):2361-2367. PubMed ID: 36394890
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of pretreatment indocyanine green angiography in the acute uveitic phase of Vogt-Koyanagi-Harada disease.
    Tobaigy MF, Abouammoh MA, AlBloushi AF, Saifaldein AA, Gikandi P, Almousa AN, Herbort CP, El-Asrar AA.
    Acta Ophthalmol; 2024 Aug 01; 102(5):e679-e686. PubMed ID: 38131519
    [Abstract] [Full Text] [Related]

  • 6. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM.
    Acta Ophthalmol; 2012 Dec 01; 90(8):e603-8. PubMed ID: 22971163
    [Abstract] [Full Text] [Related]

  • 7. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
    Urzua CA, Velasquez V, Sabat P, Berger O, Ramirez S, Goecke A, Vásquez DH, Gatica H, Guerrero J.
    Acta Ophthalmol; 2015 Sep 01; 93(6):e475-80. PubMed ID: 25565265
    [Abstract] [Full Text] [Related]

  • 8. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
    Herbort CP, Mantovani A, Bouchenaki N.
    Int Ophthalmol; 2007 Sep 01; 27(2-3):173-82. PubMed ID: 17457515
    [Abstract] [Full Text] [Related]

  • 9. A Novel Risk Stratification-Based Immunomodulatory Treatment Strategy for Vogt-Koyanagi-Harada Disease.
    Jin K, Liang A, Song H, Xiao F, Gao F, Han X, Zhang M, Zhao C.
    Am J Ophthalmol; 2024 Jun 01; 262():25-33. PubMed ID: 38369223
    [Abstract] [Full Text] [Related]

  • 10. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
    Feng H, Chen W, Yang J, Kong H, Li H, He Y, Wang H.
    BMC Ophthalmol; 2024 Jun 07; 24(1):238. PubMed ID: 38849758
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
    Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A.
    Ophthalmology; 2007 Mar 07; 114(3):606-14. PubMed ID: 17123618
    [Abstract] [Full Text] [Related]

  • 12. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, AlBloushi AF, Gikandi PW, Hardarson SH, Stefánsson E.
    Br J Ophthalmol; 2019 Dec 07; 103(12):1695-1699. PubMed ID: 30798260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, AlBloushi AF, Alzubaidi A, Gikandi PW, Stefánsson E.
    Acta Ophthalmol; 2024 Sep 07; 102(6):720-727. PubMed ID: 38470990
    [Abstract] [Full Text] [Related]

  • 15. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
    Nakayama M, Keino H, Watanabe T, Okada AA.
    Br J Ophthalmol; 2019 Feb 07; 103(2):274-278. PubMed ID: 29666121
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
    Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D.
    Acta Ophthalmol; 2013 Sep 07; 91(6):e486-93. PubMed ID: 23575246
    [Abstract] [Full Text] [Related]

  • 17. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC, Cho IH, Lee EK, Yu HG.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun 07; 255(6):1203-1211. PubMed ID: 28382438
    [Abstract] [Full Text] [Related]

  • 18. Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions.
    Knecht PB, Mantovani A, Herbort CP.
    Int Ophthalmol; 2013 Oct 07; 33(5):571-7. PubMed ID: 23277207
    [Abstract] [Full Text] [Related]

  • 19. Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
    Abu El-Asrar AM, Al Mudhaiyan T, Al Najashi AA, Hemachandran S, Hariz R, Mousa A, Al-Muammar A.
    Ocul Immunol Inflamm; 2017 Aug 07; 25(4):475-485. PubMed ID: 27003480
    [Abstract] [Full Text] [Related]

  • 20. Corticotherapy vs. Corticotherapy Plus Immunosuppressive Therapy in Acute Vogt-Koyanagi-Harada Disease.
    Concha-Del Río LE, Gómez L, Arellanes-García L.
    Arch Soc Esp Oftalmol (Engl Ed); 2018 May 07; 93(5):225-230. PubMed ID: 29258782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.